| 发明名称 |
TRICYCLIC CARBAMATE JAK INHIBITORS |
| 摘要 |
The present disclosure relates to 2,4-pyrimidinediamines substituted with tricyclic carbamates and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, such as JAK2 or JAK3, is therapeutically useful. |
| 申请公布号 |
WO2010039518(A2) |
申请公布日期 |
2010.04.08 |
| 申请号 |
WO2009US57972 |
申请日期 |
2009.09.23 |
| 申请人 |
RIGEL PHARMACEUTICALS, INC.;SINGH, RAJINDER;BHAMIDIPATI, SOMASEKHAR;MARKOVTSOV, VADIM |
发明人 |
SINGH, RAJINDER;BHAMIDIPATI, SOMASEKHAR |
| 分类号 |
C07D401/14;A61K31/42;A61K31/535;A61P35/00;A61P35/02;C07D403/14 |
主分类号 |
C07D401/14 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
